A major player of this condition is the transforming growth factor-beta (TGF-β), which can change the TME in the direction of a tumor-supportive environment through the enhancement of immuno-suppression by regulatory T cells (T-regs) activation [120]. This evidence concerns the gene TGFB1 and neoplasm.